Skip to main content
VALN
NASDAQ Life Sciences

Prospectus Filed for Resale of 31.6M Shares by Institutional Investors, Creating Significant Market Overhang

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$5.36
Mkt Cap
$503.753M
52W Low
$5.06
52W High
$12.25
Market data snapshot near publication time

Summary

Valneva has filed a prospectus for the resale of 31.6 million shares by institutional investors, creating a significant market overhang and potential dilution for existing shareholders.


Key Events

  • Significant Share Resale Registered

    Selling securityholders are registering to sell up to 31,609,140 ordinary shares, which may be represented by American Depositary Shares (ADSs).

  • Substantial Market Overhang

    The registered shares represent approximately 16.65% of the company's current outstanding shares and a value of roughly $169.4 million, or 33.6% of the market capitalization, creating significant potential supply pressure.

  • Limited Company Proceeds from Resale

    The company will not receive any proceeds from the sale of the already issued shares by the selling securityholders. However, it could potentially receive up to €47 million if all associated ABSA Warrants are exercised for cash.

  • Follows Prior Capital Raise

    This prospectus finalizes the resale mechanism for shares and warrants issued in an €84 million private placement completed on April 30, 2026, and follows the F-3 registration filed on June 4, 2026.


Analysis

Valneva has filed a prospectus enabling institutional selling securityholders to resell up to 31.6 million ordinary shares. This represents a substantial market overhang, equivalent to approximately 16.65% of the company's outstanding shares and a value of roughly $169.4 million, or 33.6% of its current market capitalization. While the company may receive up to €47 million from the exercise of associated warrants, it will not receive proceeds from the sale of already issued shares. This event follows a recent €84 million private placement and an F-3 registration, formalizing the mechanism for these shares to enter the market and potentially exerting downward pressure on the stock.

At the time of this filing, VALN was trading at $5.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $503.8M. The 52-week trading range was $5.06 to $12.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VALN - Latest Insights

VALN
Jun 16, 2026, 4:48 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $5.36
Real-time Price: $5.36 info
Change: $0 (0%) info
Market Cap: $503.753M info
VALN
Jun 04, 2026, 5:05 PM EDT
Filing Type: F-3
Importance Score:
7
Price at Filing: $5.67
Real-time Price: $5.36 info
Change: -$0.310 (-5%) info
Market Cap: $503.753M info
VALN
May 13, 2026, 4:49 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.87
Real-time Price: $5.36 info
Change: -$0.510 (-9%) info
Market Cap: $503.753M info
VALN
May 13, 2026, 1:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $6.25
Real-time Price: $5.36 info
Change: -$0.890 (-14%) info
Market Cap: $503.753M info
VALN
May 12, 2026, 5:09 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $6.00
Real-time Price: $5.36 info
Change: -$0.640 (-11%) info
Market Cap: $503.753M info
VALN
Apr 30, 2026, 5:11 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.38
Real-time Price: $5.36 info
Change: -$0.020 (-0.37%) info
Market Cap: $503.753M info
VALN
Apr 30, 2026, 1:15 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.33
Real-time Price: $5.36 info
Change: +$0.030 (+0.56%) info
Market Cap: $503.753M info
VALN
Mar 23, 2026, 4:06 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.51
Real-time Price: $5.36 info
Change: -$1.15 (-18%) info
Market Cap: $503.753M info
VALN
Mar 18, 2026, 11:21 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $11.00
Real-time Price: $5.36 info
Change: -$5.64 (-51%) info
Market Cap: $503.753M info
VALN
Mar 17, 2026, 4:33 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $11.01
Real-time Price: $5.36 info
Change: -$5.65 (-51%) info
Market Cap: $503.753M info